Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Quince Therapeutics said Brigette Roberts will become chief executive officer and John Militello chief financial officer, effective October 8, 2026, following the resignations of Dirk Thye as CEO and Brendan Hannah as COO.
Quince Therapeutics said its board appointed Brigette Roberts as chief executive officer and John Militello as chief financial officer, effective October 8, 2026. Dirk Thye resigned as CEO, chief medical officer and a director, and Brendan Hannah resigned from several officer roles.